Discontinued — last reported Q2 '19

Other

Unrecognized tax benefits

West Pharmaceutical Services Unrecognized tax benefits increased by 15.3% to $64.70M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ2 2019

How to read this metric

An increase suggests more aggressive tax positions or increased scrutiny from tax authorities, while a decrease indicates resolution of tax uncertainties.

Detailed definition

Represents the total amount of tax benefits that have been taken or are expected to be taken in tax returns but have not...

Peer comparison

Standard disclosure for large multinational corporations; peers with complex global tax structures typically report significant balances.

Metric ID: other_unrecognized_tax_benefits

Historical Data

2 periods
 Q4 '25Q1 '26
Value$56.10M$64.70M
QoQ Change+15.3%
Range$56.10M$64.70M

Frequently Asked Questions

What is West Pharmaceutical Services's unrecognized tax benefits?
West Pharmaceutical Services (WST) reported unrecognized tax benefits of $64.70M in Q1 2026.
What does unrecognized tax benefits mean?
The total value of tax positions taken that are not yet fully recognized in financial reporting due to uncertainty.